Literature DB >> 21739384

Efficacy and safety of the combination imidacloprid 10 % / moxidectin 1.0 % spot-on (Advocate(®) spot-on for small cats and ferrets) in the treatment of ear mite infection (Otodectes cynotis) in ferrets.

Christophe Le Sueur1, Sophie Bour, Roland Schaper.   

Abstract

In this study, the efficacy and safety of a treatment with the combination imidacloprid 10 %/ moxidectin 1.0 % spot-on (Advocate(®) spot-on for small cats and ferrets) was tested in 39 ferrets naturally infested with ear mites (Otodectes cynotis). The study was performed as a multicentre, non-randomised, non-controlled (all study animals were treated) and non-blinded clinical field study in two French veterinary practices. Four visits (day (D) 0 = inclusion and first treatment, D14 = second treatment, D28 = possible third treatment, D56 = termination) were planned. The dosage was one pipet per ferret (designed for cats weighing up to 4 kg, corresponding to a dose of moxidectin ranging from 2.2 to 5 mg/kg body weight) two or three times at 14-days intervals (at D0, D14 and possibly D28 depending on the parasitological examination of the ears at D28). The main efficacy criterion was the absence of the parasite (all stages incl. eggs, larvae, nymphs and adults) from ear scrapings by microscopic examination. At D28 after two treatments (D0 and D14), 76.9 % (30/39) of animals were cured. Only 23 % (9/39) needed a third treatment. At day 56, 100 % were cured. Local symptoms (inflammation and pruritus) were consistently improved (50.6 % improvement at D14, 81.0 % at D28 and 97.9 % at D56) as well as the abnormal cerumen production (14.7 % improvement at D14, 77.7 % at D28 and 100.0 % at D56). No general symptoms were noticed during the study (general health and skin aspect). Advocate(®) spot-on for small cats and ferrets is an effective and safe treatment for ear mite infection in ferrets. Two or three treatments administered in 14-days intervals to ferrets infested with ear mites provided 100 % parasitological cure on D56.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21739384     DOI: 10.1007/s00436-011-2411-7

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  6 in total

1.  Evaluation of the efficacy of an imidacloprid 10%/moxidectin 1% spot-on against Otodectes cynotisin cats.

Authors:  L J Fourie; D J Kok; J Heine
Journal:  Parasitol Res       Date:  2003-08-19       Impact factor: 2.289

2.  Efficacy and safety of selamectin in the treatment of Otodectes cynotis infestation in domestic ferrets.

Authors:  D S Miller; R P Eagle; S Zabel; R Rosychuk; T W Campbell
Journal:  Vet Rec       Date:  2006-11-25       Impact factor: 2.695

3.  Efficacy and safety of imidacloprid 10% plus moxidectin 2.5% spot-on in the treatment of sarcoptic mange and otoacariosis in dogs: results af a European field study.

Authors:  K Krieger; J Heine; P Dumont; K Hellmann
Journal:  Parasitol Res       Date:  2005-10       Impact factor: 2.289

4.  Efficacy of imidacloprid 10%/moxidectin 1% (Advocate/Advantage Multi) against fleas (Ctenocephalides felis felis) on ferrets (Mustela putorius furo).

Authors:  Ulf Wenzel; Josef Heine; Heidrun Mengel; Franziska Erdmann; Roland Schaper; Simon Heine; Arwid Daugschiess
Journal:  Parasitol Res       Date:  2008-06       Impact factor: 2.289

5.  Validity of species status of the parasitic mite Otodectes cynotis.

Authors:  J Lohse; H Rinder; R Gothe; M Zahler
Journal:  Med Vet Entomol       Date:  2002-06       Impact factor: 2.739

6.  Otodectes cynotis (Acari: Psoroptidae): examination of survival off-the-host under natural and laboratory conditions.

Authors:  Domenico Otranto; Piermarino Milillo; Paola Mesto; Donato De Caprariis; Stefania Perrucci; Gioia Capelli
Journal:  Exp Appl Acarol       Date:  2004       Impact factor: 2.132

  6 in total
  1 in total

1.  Efficacy of a combination of 10% imidacloprid and 1% moxidectin against Caparinia tripilis in African pygmy hedgehog (Atelerix albiventris).

Authors:  Kyu-Rim Kim; Kyu-Sung Ahn; Dae-Sung Oh; Sung-Shik Shin
Journal:  Parasit Vectors       Date:  2012-08-07       Impact factor: 3.876

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.